0
0

Cart (0)

Home > Isotope Labelled Standards > Tegoprazan

Tegoprazan - Isotope Labelled Standards
Wishlist
Select options

Tegoprazan D6

  • CAT NUMBER DCTI-A-389
  • CAS NUMBER NA
  • MOLECULAR FORMULA C20H13D6F2N3O3
  • MOLECULAR WEIGHT 393.42
Select options
Wishlist
References
FAQ's

References

  1. Hanazawa, Takeshi; Koike, Hiroki, Chromane Substituted Benzimidazoles And Their Use As Acid Pump Inhibitors, Pfizer Inc., Japan, RaQualia Pharma Inc., Japan, EP1963311B1, June 16, 2010  
  1. Kim, Joohwan; Kim, Sungjun; Noh, Hyun-Jung; Ryu, Shin-Young; Kim, Soo-Jin, Simultaneous quantification of tegoprazan and its major metabolite M1 in dog plasma using liquid chromatography-tandem mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis Volume: 171, Pages: 99-103, 2019

Frequently Asked Questions

Liquid chromatography/tandem mass spectrometry (LC-MS/MS) can detect impurities effectively in Tegoprazan.

The presence of impurities in Tegoprazan can have implications for patient safety. Different types and levels of impurities can cause adverse effects or compromise the efficacy of the medication.

Acetonitrile is used to achieve optimal solubility and separation of Tegoprazan impurities.

Tegoprazan impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart